One of this week's major news items in the world of pharma is the less-than-enthusiastic response of an FDA panel to Boehringer-Ingelheim's experimental "sexual desire for women" pill, flibanserin. I …
Impactiviti Daily 051910 Top Pharma News
***** TODAY’S NEWS Sometimes I can't help but voice a bit of skepticism, especially when it comes to sexual disorder treatments. So, count me as less than convinced about this experimental treatment …
Continue Reading about Impactiviti Daily 051910 Top Pharma News →
Impactiviti Daily 111709
Whew! The back-to-back conference marathon is now over, and we can get back to our regular pharma news reporting. Here's what's up today... TODAY’S NEWS Everyone's talking about the Zetia/Niaspan …